Tango Therapeutics, Inc.TNGXNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank83
3Y CAGR+8.0%
5Y CAGR+24.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+8.0%/yr
Annual compound
5Y CAGR
+24.1%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $171.39M | -8.7% |
| 2024 | $187.66M | +24.5% |
| 2023 | $150.70M | +10.9% |
| 2022 | $135.93M | +42.7% |
| 2021 | $95.23M | +63.5% |
| 2020 | $58.23M | +672.6% |
| 2019 | $7.54M | - |